Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for ReGen Biologics Inc. -.--% -

Valuation: ReGen Biologics Inc.

Market Cap 1.17M 1.02M 951K 874K 1.65M 112M 1.68M 11.22M 4.39M 55.76M 4.41M 4.31M 185M P/E 2007
-0.9x
P/E 2008 -1.66x
Enterprise Value 11.46M 9.96M 9.28M 8.53M 16.1M 1.09B 16.38M 110M 42.89M 544M 43.03M 42.08M 1.8B EV / Sales 2007
14x
EV / Sales 2008 22.7x
Free-Float
100%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
+1.34%+3.94%-15.85%-1.38% 183B
+1.51%+4.17%-2.98%+1.43% 109B
-0.95%-0.49%+6.94%+61.09% 60.57B
+2.37%+2.85%+44.34%+56.22% 51.8B
+2.77%+8.86%-3.49%-38.38% 45.64B
+3.03%+4.44% - - 33.22B
+4.63%+22.04%+10.13%-29.48% 31.49B
+2.05%+6.01%+45.42%-6.11% 24B
+1.86%+8.67%+2.54%+2.12% 22.26B
Average +1.86%+4.06%+10.88%+5.69% 56.12B
Weighted average by Cap. +1.67%+3.37%+1.52%+7.08%

Financials

2007 2008
Net sales 986K 857K 799K 734K 1.39M 93.99M 1.41M 9.43M 3.69M 46.85M 3.7M 3.62M 155M 1.37M 1.19M 1.11M 1.02M 1.93M 131M 1.96M 13.14M 5.14M 65.29M 5.16M 5.05M 216M
Net income -10.38M -9.02M -8.41M -7.73M -14.58M -989M -14.83M -99.23M -38.84M -493M -38.97M -38.11M -1.63B -9.95M -8.65M -8.06M -7.41M -13.98M -949M -14.22M -95.15M -37.25M -473M -37.37M -36.55M -1.57B
Net Debt 4.09M 3.56M 3.32M 3.05M 5.75M 390M 5.85M 39.14M 15.32M 194M 15.37M 15.03M 645M 10.28M 8.94M 8.33M 7.66M 14.45M 980M 14.7M 98.35M 38.5M 489M 38.62M 37.77M 1.62B
Logo ReGen Biologics Inc.
Regen Biologics Inc (ReGen) is a United States-based development stage orthopedic products company. The Company develops, manufactures and markets tissue growth and repair products for United States and global markets. The Company's collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. Some of these applications are marketable while others are in various stages of development. Its approved product using its collagen matrix technology is the Menaflex collagen meniscus implant device (also known as the CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey, and the Republic of South Africa, through the Company’s subsidiary, ReGen Biologics AG.
Employees
-
  1. Stock Market
  2. Stocks
  3. RGBOQ Stock